Search Login Register
Medroxyprogesterone Acetate
(Depo-Provera)
Summary
Description:
A synthetic progestin that is derived from 17-hydroxyprogesterone. It is a long-acting contraceptive that is effective both orally or by intramuscular injection and has also been used to treat breast and endometrial neoplasms.
Also Known As:
Depo-Provera; Provera; Curretab; Cycrin; Acetate, Medroxyprogesterone Show All >>
Networked: 1694
relevant articles (99 outcomes,
359 trials/studies)
for this Drug
Key Diseases for which Medroxyprogesterone Acetate is
Relevant
-
Breast Neoplasms (Breast Cancer)
:
23 outcomes 89 studies in 354 results
-
Endometriosis (Adenomyosis)
:
11 outcomes 15 studies in 68 results
-
Neoplasms (Cancer)
:
9 outcomes 45 studies in 238 results
-
Hemorrhage
:
8 outcomes 20 studies in 124 results
-
Endometrial Neoplasms (Endometrial Cancer)
:
6 outcomes 19 studies in 114 results
Show All >>
Drugs Related to Medroxyprogesterone Acetate
-
Medroxyprogesterone Acetate (Depo-Provera)
-
Estrogens (Estrogen)
-
N,N-dimethyl-4-anisidine (DMPA)
-
Tamoxifen
-
Conjugated (USP) Estrogens (Premarin)
-
Estradiol (Estrace)
-
Megestrol Acetate (Borea)
-
Gonadotropin-Releasing Hormone (GnRH)
-
doxifluridine
-
Progestins (Progestagens)
Show All >>
Therapies Related to Medroxyprogesterone Acetate
-
Contraception (Birth Control)
-
Injections
-
Drug Therapy (Chemotherapy)
-
Estrogen Replacement Therapy
-
Intramuscular Injections
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.